These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22161170)

  • 1. Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide 1 levels.
    Valderas JP; Ahuad J; Rubio L; Escalona M; Pollak F; Maiz A
    Obes Surg; 2012 Apr; 22(4):582-6. PubMed ID: 22161170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide.
    Øhrstrøm CC; Worm D; Højager A; Andersen D; Holst JJ; Kielgast UL; Hansen DL
    Diabetes Obes Metab; 2019 Sep; 21(9):2142-2151. PubMed ID: 31144430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of acarbose and dietary modifications to limit glycemic variability following Roux-en-Y gastric bypass as assessed by continuous glucose monitoring.
    Ritz P; Vaurs C; Bertrand M; Anduze Y; Guillaume E; Hanaire H
    Diabetes Technol Ther; 2012 Aug; 14(8):736-40. PubMed ID: 22853724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.
    Salehi M; Gastaldelli A; D'Alessio DA
    Gastroenterology; 2014 Mar; 146(3):669-680.e2. PubMed ID: 24315990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass.
    Tharakan G; Behary P; Wewer Albrechtsen NJ; Chahal H; Kenkre J; Miras AD; Ahmed AR; Holst JJ; Bloom SR; Tan T
    Eur J Endocrinol; 2017 Dec; 177(6):455-464. PubMed ID: 28855269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for Relationship Between Early Dumping and Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass.
    Øhrstrøm CC; Worm D; Kielgast UL; Holst JJ; Hansen DL
    Obes Surg; 2020 Mar; 30(3):1038-1045. PubMed ID: 31907828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects.
    Vidal J; Nicolau J; Romero F; Casamitjana R; Momblan D; Conget I; Morínigo R; Lacy AM
    J Clin Endocrinol Metab; 2009 Mar; 94(3):884-91. PubMed ID: 19106269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive hypoglycaemia due to late dumping syndrome: successful treatment with acarbose.
    Imhof A; Schneemann M; Schaffner A; Brändle M
    Swiss Med Wkly; 2001 Feb; 131(5-6):81-3. PubMed ID: 11383230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More symptoms but similar blood glucose curve after oral carbohydrate provocation in patients with a history of hypoglycemia-like symptoms compared to asymptomatic patients after Roux-en-Y gastric bypass.
    Laurenius A; Werling M; Le Roux CW; Fändriks L; Olbers T
    Surg Obes Relat Dis; 2014; 10(6):1047-54. PubMed ID: 25205571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting levels of glicentin are higher in Roux-en-Y gastric bypass patients exhibiting postprandial hypoglycemia during a meal test.
    Poitou C; Bouaziz-Amar E; Genser L; Oppert JM; Lacorte JM; Le Beyec J
    Surg Obes Relat Dis; 2018 Jul; 14(7):929-935. PubMed ID: 29703503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass.
    Jonsson I; Bojsen-Møller KN; Kristiansen VB; Veedfald S; Wewer Albrechtsen NJ; Clausen TR; Kuhre RE; Rehfeld JF; Holst JJ; Madsbad S; Svane MS
    Front Endocrinol (Lausanne); 2021; 12():681116. PubMed ID: 34084153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics.
    Lee A; Patrick P; Wishart J; Horowitz M; Morley JE
    Diabetes Obes Metab; 2002 Sep; 4(5):329-35. PubMed ID: 12190996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia.
    Mulla CM; Goldfine AB; Dreyfuss JM; Houten S; Pan H; Pober DM; Wewer Albrechtsen NJ; Svane MS; Schmidt JB; Holst JJ; Craig CM; McLaughlin TL; Patti ME
    Obes Surg; 2019 Jul; 29(7):2092-2099. PubMed ID: 30976983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
    Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
    Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report.
    Zheng MY; Yang JH; Shan CY; Zhou HT; Xu YG; Wang Y; Ren HZ; Chang BC; Chen LM
    Cardiovasc Diabetol; 2013 May; 12():73. PubMed ID: 23642288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutrient re-routing and altered gut-islet cell crosstalk may explain early relief of severe postprandial hypoglycaemia after reversal of Roux-en-Y gastric bypass.
    Svane MS; Toft-Nielsen MB; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S; Bojsen-Møller KN
    Diabet Med; 2017 Dec; 34(12):1783-1787. PubMed ID: 28782840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
    Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial.
    Chronaiou A; Tsoli M; Kehagias I; Leotsinidis M; Kalfarentzos F; Alexandrides TK
    Obes Surg; 2012 Nov; 22(11):1761-70. PubMed ID: 22911148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects.
    Arakawa M; Ebato C; Mita T; Fujitani Y; Shimizu T; Watada H; Kawamori R; Hirose T
    Metabolism; 2008 Sep; 57(9):1299-306. PubMed ID: 18702958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.